3 results
Approved WMOCompleted
The primary objective of this trial is to provide early access to TMC125 for treatment-experienced HIV-1 infected patients who have failed multiple ARV regimens and have limited treatment options with the currently approved antiretrovirals.The…
Approved WMOPending
Part A: To characterize the safety, tolerability, and define the MTD or RP2D for the combination of relatlimab + nivolumab in pediatric participants less than 18 years of age with R/R cHL and NHL.Part A: To characterize the PK of relatlimab for the…
Approved WMORecruiting
1) Objective: To compare pembrolizumab plus chemotherapy to placebo plus chemotherapy with respect to PFS